<DOC>
	<DOCNO>NCT00501397</DOCNO>
	<brief_summary>The purpose research study evaluate effect several daily dos ketoconazole ( medication use treat fungal infection like athlete 's foot ) single dose GSK189075 ( experimental diabetes drug ) , also evaluate safety tolerability GSK189075 healthy volunteer . The study see whether ketoconazole cause GSK189075 stay bloodstream longer period time . It also examine whether GSK189075 cause change amount glucose urine .</brief_summary>
	<brief_title>A Study Effects Ketoconazole Taken Orally Has PK Profiles Dose GSK189075 Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Ketoconazole</mesh_term>
	<criteria>Are healthy , nonsmoking male female . Are 18 55 year old , inclusive . Have body weight &gt; equal 110 pound . Are female unable child negative pregnancy test . Are willing able provide write informed consent start studyrelated procedure . Are able understand comply protocol requirement , instruction , protocolstated restriction . Smoke use tobacco product . Have know allergic reaction ketoconazole study drug . Have history regular alcohol consumption great 7 drink per week female great 14 drink per week male . Have positive drug alcohol smoke test screening checkin clinic . Have participate another clinical trial within 30 day prior screen receive investigational drug . Have donate pint blood within 56 day first dose study drug . Have know suspected stomach condition ( stomach surgery within 6 month prior dose ) . Have abnormal liver test result . Have document history diagnosis cirrhosis . Have positive result hepatitis C B , HIV screen . Have blood pressure outside normal range . Are male subject unwilling either abstain sexual activity unwilling use birth control course study . Are use nonprescription drug , vitamin , herbal dietary supplement ( include St John 's Wort ) within 7 day first dose study medication , Have abnormality identify screen physical laboratory examination study physician feel would make inappropriate participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>ketoconazole ,</keyword>
	<keyword>drug interaction ,</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>T2DM ,</keyword>
</DOC>